Clindamycin Phosphate
- Product NDC
- 10135-691
- 11-digit product format
- 101350691
- Labeler code
- 10135
- Product ID
- 10135-691_ec98a8b7-7c90-6912-e053-2a95a90a2791
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Clindamycin Phosphate
- Dosage form
- SOLUTION
- Route
- TOPICAL
- Labeler
- Marlex Pharmaceuticals Inc
- Application
- ANDA209846
- Marketing category
- ANDA
- Marketing start
- 2020-03-01
- Marketing end
- 0000-00-00
- Substance
- CLINDAMYCIN PHOSPHATE
- Active strength
- 12 mg/mL
- Pharmacologic classes
- Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 10135-691-61 | Clindamycin Phosphate | 1 in 1 CARTON | SOLUTION | 1 | | 4 |
| 10135-691-61 | Clindamycin Phosphate | 60 mL in 1 BOTTLE, WITH APPLICATOR | SOLUTION | 60 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 10135-691 | CLINDAMYCIN PHOSPHATE SOLUTION [MARLEX PHARMACEUTICALS INC] | 4 | Legacy NDC, 2 package rows | 20221104_ab4e9054-348c-4e7b-ae04-1163ac9a15f9.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 10135-691-61 | 10135069161 | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (10135-691-61) > 60 mL in 1 BOTTLE, WITH APPLICATOR | 2020-03-01 | 0000-00-00 | No | No | Current |